- Biomarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes.
- Biomarin focuses on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases
- The patient populations suffering from these rare diseases are mostly children
- Some of the diseases Biomarin focuses on have less than 1,000 cases.
- The conditions they create therapies for are often inherited, and often difficult to diagnose.
- Biomarin strives to develop important therapies for them as quickly as possible.
- Biomarin has an impressive record of quickly developing treatments and therapies.
- Sources for global clinical trial information, such as CenterWatch, have named Biomarin one of the fastest drug developers in the industry.
- Biomarin is a world leader in metabolic disease innovation.
- Biomarin pursues to study early-stage science that has the potential to change the course of disease.
My question is:
How long does it typically take to create a working therapeutic cure for a disease?